Arrow
Arrotex bolsters pharmacy offering
Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic …
A new group
Arrow and Apotex have now merged to form Arrotex – claiming a 50% share in the Australian generic pharmacy market Arrow Pharmaceuticals and Apotex Australia have completed the merger announced …
Looking deeper
The ACCC is investigating whether the proposed merger of Arrow and Apotex – two of the largest suppliers of generics in Australia – will impact on competition In early May, …
Under review
The ACCC has launched a review into the proposed merger of Arrow and Apotex Early last month, Arrow Pharmaceuticals and Apotex announced a proposed merger of their Australian and New …
A proposed merger
Arrow and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations The proposed merger between Arrow Pharmaceuticals and Apotex is still subject …
Strides buys at Aspen, revives Arrow Pharmaceuticals
Indian pharma company Strides Arcolab has acquired Aspen business in Australia and plans to run the business as Arrow Pharmaceuticals, bringing back a previous name in the Australian generics market. …